路透上海8月20日 - 中国股市沪综指周四略反弹收高，医药板块领涨，此前海外mRNA癌症疫苗临床试验取得突破性进展。
沪综指.SSEC收升0.2%至3,903.72点，沪深300指数.CSI300收涨0.1%。深圳创业板指数.CNT收升0.6%，上证科创板50成分指数.STAR50收低0.9%。
中山证券在报告中表示，短期情绪释放后存在超跌反弹可能，但需观察外围企稳信号。需关注后续美债收益率走势以及近期的国际油价变化，若美债利率有所回落，则成长赛道有望迎来估值修复窗口。
中证医药100指数.CSI000978收涨4.4%，疫苗生产商康希诺A股688185.SS一字涨停。
美国制药公司莫德纳(Moderna)MRNA.O和默克MRK.N周三表示，后期临床试验显示，其个性化mRNA癌症疫苗Intismeran可降低黑色素瘤复发和扩散风险。这是癌症治疗新领域的一项重大突破。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.